Recent Updates
Recently added Catalysts
PTGX Positive Sentiment

U.S. FDA Approves MIMRYLO™ (rusfertide)

Key Takeaway: Protagonist has received FDA approval for its drug MIMRYLO™ (rusfertide), marking a significant achievement for the company. The approval highlights Protagonist's commitment to innovation and its diverse corporate culture, which includes a significant representation of underrepresented communities. The company emphasizes the importance of a supportive workplace that fosters growth and inclusivity.
Price reaction · baseline $149.5 (2026-08-27 close) · hit pre-market · 1 other PTGX headline(s) in the window, move may be shared
day 0 close · peak
-3.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • FDA approval of MIMRYLO™ (rusfertide) is a significant milestone.
  • Protagonist's commitment to diversity and inclusion enhances innovation.
  • A diverse workforce is seen as critical for long-term success.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+61%
120-day peak, hindsight
Typical move
6%
average across 11 past catalysts
Lead asset
PN-943
Phase 2 · Ulcerative Colitis Chronic Moderate

Full Press Release Details

Protagonist: Inclusion by the Numbers

Spotlight: Carena Spivey, Head of HR

Carena, equality, inclusion, and workplace diversity have long been in focus at Protagonist, as expressed through various programs and initiatives. Can you tell us about your approach?

We view our diverse and welcoming corporate culture as being critical to our long-term success – It’s essential to the way we innovate. And we regularly track and report our progress, because we believe that what doesn’t get measured doesn’t get done. Today: - 65% of employees are members of underrepresented ethnic communities - 51% are women - nearly 50% of our Board identifies as a member of an underserved community or as female

What are you doing to help create a more diverse employee community?

We create the conditions for our employees to thrive, facilitating their learning and growth through a richly supportive workplace setting.
Part of that is creating a speak-up culture; we have cultivated an environment where every voice is heard, and we encourage the expression of different points of view in decision-making processes. At every turn, we encourage deep listening, thoughtful consideration, and open-mindedness that allows for decisions to be changed or refined in step with new data. By embracing our team members’ differences, we create wins for our organization and for patients.

Frequently Asked Questions

What is MIMRYLO™ (rusfertide)?

MIMRYLO™ (rusfertide) is a drug recently approved by the FDA.

Why is diversity important at Protagonist?

Diversity is viewed as critical for innovation and long-term success at Protagonist.

How does Protagonist support workplace diversity?

Protagonist fosters a supportive environment that encourages learning and growth.

What percentage of Protagonist's workforce is diverse?

65% of employees belong to underrepresented ethnic communities, and 51% are women.

Last updated: Aug 28, 2026